Ann: Material Revenues Confirmed from Non-Pharma Business Units, page-99

Has anyone heard of inCann ? I can't recall it coming up in any releases from MXC.

Just came across this (10 Cannabis companies in Australia)

MGC Pharmaceuticals is a specialist medical cannabis company with a focus on phytocannabinoid-based medicine for the biopharmaceutical sector. The company aims to bring its cannabinoid-based pharmaceuticals to medical markets such as Europe, North America and Australasia, which includes Australia, New Zealand, New Guinea and other islands in that region.

The company is targeting medical conditions such as epilepsy and Alzheimer’s disease and has three core products: the CannEpil, which is an oral oil treatment for seizures associated with drug resistant epilepsy; CogniCann, which is an oral spray using a specific THC:CBD ratio for dementia symptoms; and InCann, which is an oral solution that treats Crohn’s disease and colitis.